Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Mean Annual Healthcare Expenditures of the Sampled Population, with Comparisons to the Non-elderly US Population (in US Dollars, $)

From: The economic impact of chronic fatigue syndrome in Georgia: direct and indirect costs

Unadjusted sample means, weighted to account for sample design
  Healthcare Expenditure Category
Sample Inpatient Hospitalization, mean costs
($2005)
Ambulatory Provider visits
mean costs
($2005)
Rx Medications,
mean costs
($2005)
OTC Medications and other healthcare costs;
mean costs
($2005)
CFS 902 3,217 1,347 217
ISF 484 1,702 648 134
NF 303 1,406 294 93
Study Sample 435 1,665 546 122
US non-elderly adult Population* 801 1,474 624 64
  1. *US population estimates based on 2005 MEPS, age 18-59; The MEPS estimate of 'other' costs includes OTC medications. Rx = Prescription; OTC = non-prescription ('over-the-counter').